Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease

Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease

Chronic lymphocytic leukaemia (CLL) is characterised by the expansion of a neoplastic mature B cell clone. CLL clinical outcome is very heterogeneous, with some subjects never requiring therapy and some showing an aggressive disease. Genetic and epigenetic alterations and pro-inflammatory microenvir...

Full description

Bibliographic Details
Main Authors:	Valentina Rubino, Flavia Carriero, Anna Teresa Palatucci, Angela Giovazzino, Stefania Leone, Valerio Nicolella, Martina Calabrò, Rosangela Montanaro, Vincenzo Brancaleone, Fabrizio Pane, Federico Chiurazzi, Giuseppina Ruggiero, Giuseppe Terrazzano
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	International Journal of Molecular Sciences
Subjects:	chronic lymphocytic leukaemia HLA class I molecules cytotoxic T cells NK cells immune activation profile
Online Access:	https://www.mdpi.com/1422-0067/24/11/9596

Similar Items

Regulatory T<sub>R3-56</sub> Cells in the Complex Panorama of Immune Activation and Regulation
by: Flavia Carriero, et al.
Published: (2023-12-01)

An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
by: Giuseppe Terrazzano, et al.
Published: (2020-05-01)

Killer-Cell Immunoglobulin-like Receptor Diversity in an Admixed South American Population
by: Marlon Castrillon, et al.
Published: (2022-09-01)

A case of leukaemia cutis in a dog with T‐cell chronic lymphocytic leukaemia
by: Hyeona Bae, et al.
Published: (2022-05-01)

Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2
by: Sanja Perkovic, et al.
Published: (2012-09-01)

Ally to adversary: mesenchymal stem cells and their transformation in leukaemia
by: Mugdha Sharma, et al.
Published: (2019-05-01)

Function of natural killer cells in immune defence against human leukemia
by: A Wodnar-Filipowicz, et al.
Published: (2006-06-01)

Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse
by: Virginia Santiago, et al.
Published: (2018-10-01)

Plasmablastic myeloma progressed to plasma cell leukaemia
by: Ke Xu, et al.
Published: (2021-11-01)

Trans-population graph-based coverage optimization of allogeneic cellular therapy
by: Sapir Israeli, et al.
Published: (2023-05-01)

EFFECTOR FUNCTIONS OF NATURAL KILLER CELL SUBSETS IN THE CONTROL OF HAEMATOLOGICAL MALIGNANCIES
by: Angela eGismondi, et al.
Published: (2015-11-01)

Obtaining Gene-Modified HLA-E-Expressing Feeder Cells for Stimulation of Natural Killer Cells
by: Nadezhda A. Alekseeva, et al.
Published: (2024-01-01)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
by: Michał K. Zarobkiewicz, et al.
Published: (2022-02-01)

Concurrence of chronic lymphocytic leukaemia/small lymphocytic lymphoma and acute myeloid leukaemia in a bone marrow biopsy
by: Stefano Licci
Published: (2020-10-01)

Use of V H, D and J H immunoglobulin gene segments in Brazilian patients with chronic lymphocytic leukaemia (CLL)
by: Beatriz Jatobá Pimentel, et al.
Published: (2008-01-01)

Indolent, T-cell, large granular lymphocytic leukaemia in a dog presenting with severe neutropenia and an absence of lymphocytosis
by: James Elliott, et al.
Published: (2018-04-01)

Morphology of leukaemias
by: W. Ladines-Castro, et al.
Published: (2016-04-01)

Megakaryoblasts in pleural fluid in neonate with transient leukaemia of Down's syndrome
by: Karolina Chmielowiec, et al.
Published: (2023-05-01)

Effect of a Weight Loss Program on Biochemical and Immunological Profile, Serum Leptin Levels, and Cardiovascular Parameters in Obese Dogs
by: Diego Piantedosi, et al.
Published: (2020-08-01)

Targeting BCR-ABL1-positive leukaemias: a review article
by: Steven Leak, et al.
Published: (2023-01-01)

Whole body‐diffusion weighted imaging for the assessment of treatment response in hairy cell leukaemia: A positive first step
by: Ashwin Algudkar, et al.
Published: (2021-05-01)

Decidual γδT cells of early human pregnancy produce angiogenic and immunomodulatory proteins while also possessing cytotoxic potential
by: Jasper Nörenberg, et al.
Published: (2024-03-01)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
by: Shafiq Murad, et al.
Published: (2022-05-01)

High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han
by: Sudan Tao, et al.
Published: (2021-04-01)

NK cells blur the frontier between innate and acquired immunity.
by: Ennio eCarbone, et al.
Published: (2013-01-01)

Mini review of metabolism in leukaemia: from complexity to the clinic
by: Kevin M. Rattigan
Published: (2024-01-01)

Transcriptional Regulation by the NFAT Family in Acute Myeloid Leukaemia
by: Shaun D. Patterson, et al.
Published: (2021-08-01)

Increased Susceptibility of the CD57<sup>−</sup> NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response
by: Anastasia I. Palamarchuk, et al.
Published: (2021-12-01)

The impact of NKG2A and NKG2D receptors and HLA-E and MICA ligands polymorphisms on post-transplant complications after paediatric allogeneic HSCT: a single-centre experience
by: Jagoda Siemaszko, et al.
Published: (2023-06-01)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
by: Silvia D’Amico, et al.
Published: (2021-11-01)

Expression of NK Cell Receptor Ligands on Leukemic Cells Is Associated with the Outcome of Childhood Acute Leukemia
by: María Victoria Martínez-Sánchez, et al.
Published: (2021-05-01)

NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain
by: Gia-Gia T. Hò, et al.
Published: (2020-06-01)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
by: Barbara Seliger, et al.
Published: (2022-08-01)

Therapeutic Targeting of the Leukaemia Microenvironment
by: Vincent Kuek, et al.
Published: (2021-06-01)

THE INCIDENCE OF LEUKAEMIA IN KYRGYZSTAN IN CHILDREN UNDER 5 YEARS
by: A.A. USENOVA
Published: (2018-03-01)

Evaluation of the cytogenetic profile in patients with acute leukaemia
by: Nagaraj V Kulkarni, et al.
Published: (2023-07-01)

Hairy Cell Leukaemia in Oman Four cases
by: Arundathi Kurukulasuriya, et al.
Published: (2008-11-01)

Case report<Br>Graves’ thyrotoxicosis in a patient with metastatic differentiated thyroid carcinoma and chronic lymphocytic leukaemia (CLL)
by: Jacek Makarewicz, et al.
Published: (2007-06-01)

Ibrutinib protects T cells in patients with CLL from proliferation-induced senescence
by: Joanne E. Davis, et al.
Published: (2021-11-01)

Non-classical HLA-E restricted CMV 15-mer peptides are recognized by adaptive NK cells and induce memory responses
by: Nerea Martín Almazán, et al.
Published: (2023-09-01)